Every story in this section, newest first — page 302 of 373.
Graphic Packaging Holding (NYSE:GPK) shares tumbled in early trading Tuesday after the consumer packaging giant issued a 2026 profit forecast that trailed analyst expectations, overshadowing a slight revenue beat for the final quarter of 2025.
Spire (NYSE:SR) reported fiscal first-quarter earnings that surpassed analyst expectations, bolstered by higher regulatory rates and an aggressive expansion of its natural gas storage and midstream capabilities.
Madison Square Garden Entertainment (NYSE:MSGE) reported fiscal second-quarter revenue that surpassed Wall Street expectations, fueled by a record-breaking season for its "Christmas Spectacular" production.
Mueller Industries (NYSE:MLI) reported a record-breaking fiscal year 2025, even as fourth-quarter earnings fell short of analyst estimates amid volatile raw material costs.
Galaxy Digital (NASDAQ:GLXY) posted a fourth-quarter net loss of $482 million, as a downturn in digital asset prices outweighed operational milestones including a Nasdaq listing and a major infrastructure expansion in Texas.
New York-based PJT Partners (NYSE:PJT) today reported record financial results for the fourth quarter and full year ended December 31, 2025, driven by strong performance across its advisory businesses.
Pentair (NYSE:PNR) reported fourth-quarter and full-year 2025 results on Tuesday, February 3, 2026, delivering a "beat and raise" performance that secured its place in one of the stock market's most exclusive clubs.
New York-based Rithm Capital (NYSE:RITM) reported decisive progress in its transformation into a global alternative asset manager, with full-year 2025 earnings available for distribution (EAD) reaching $1.3 billion, or $2.35 per share, delivering a 19% return on equity that significantly outpaced the prior year.
ARKO (NASDAQ:ARKO) announced preliminary fourth-quarter and full-year 2025 financial results on Tuesday, February 3, 2026, coinciding with a major strategic milestone: the launch of an initial public offering (IPO) roadshow for its subsidiary, ARKO Petroleum Corp (APC).
TransDigm Group (NYSE:TDG) Tuesday reported fiscal first-quarter 2026 results, delivering double-digit growth driven by a resilient commercial aerospace aftermarket and intensifying defense spending.
PayPal Holdings (NASDAQ:PYPL) today announced fourth-quarter and full-year 2025 results, marking a pivotal turning point in its multi-year turnaround.
Atlanta-based RPC (NYSE:RES), a leading provider of oilfield services, reported financial results for the fourth quarter and full year ended December 31, 2025.
Pfizer (NYSE:PFE) reported fourth-quarter and full-year 2025 results on Tuesday, February 3, 2026, signaling a definitive shift away from its pandemic-era reliance.
Merck (NYSE:MRK) today reported fourth-quarter and full-year 2025 results that showcased a tale of two portfolios: a surging oncology and respiratory business set against a dramatic collapse in vaccine demand from China.
Marathon Petroleum (NYSE:MPC) reported fourth-quarter and full-year 2025 results on Tuesday, February 3, 2026, punctuated by a massive rebound in refining profitability and a peer-leading capital return program.
MPLX LP (NYSE:MPLX) reported fourth-quarter and full-year 2025 results on Tuesday, delivering record adjusted EBITDA of $7 billion and reinforcing its position as a primary cash engine for parent company Marathon Petroleum (NYSE:MPC).
CorVel (NASDAQ:CRVL) reported strong financial results for the quarter and nine months ended December 31, 2025, driven by the aggressive integration of generative and "agentic" artificial intelligence across its risk management platforms.
Ingredion (NYSE:INGR) reported record full-year 2025 results on Tuesday, underscoring the resilience of its high-margin specialty ingredients despite operational headwinds in North America.
Atkore (NYSE:ATKR) reported first-quarter fiscal 2026 results on Tuesday, February 3, 2026, revealing a sharp decline in profitability as the company navigates a challenging "pricing normalization" cycle in its core electrical conduit business.
Archer Daniels Midland (NYSE:ADM) reported fourth-quarter and full-year 2025 results on Tuesday that reflected a challenging cyclical downturn for the global grain giant.
Ball Corporation (NYSE:BALL) reported fourth-quarter and full-year 2025 results on Tuesday that showcased record cash flow and a massive shareholder return program, even as the company navigated the final phase of its post-aerospace-divestiture restructuring.
Massimo Group (NASDAQ:MAMO) announced on Tuesday that it has entered into a non-binding letter of intent to acquire 100% of FST Development Company, a move that signals the powersports manufacturer’s aggressive pivot toward AI-driven hardware and digital health robotics.
Vertex Pharmaceuticals (NASDAQ:VRTX) and WuXi Biologics announced a major license and research service agreement on Monday, February 2, 2026, aimed at developing an innovative trispecific T-cell Engager (TCE) for B-cell mediated autoimmune diseases.
Leiden, Netherlands-based Pharming Group (NASDAQ:PHARM) provided 2026 financial guidance and detailed its rare disease pipeline at its Investor Day on February 3, 2026.
